Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity

Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity

Background: Although Bevacizumab (BVZ) and Sunitinib (SNT) prolong survival in cancer patients, an unanticipated side-effect is cardiotoxicity. Early indices of left ventricular (LV) systolic dysfunction would be useful to address the cardiac safety of anti-cancer drugs. Objective: Whether cardia...

Full description

Bibliographic Details
Main Author: Bordun, Kimberly-Ann
Other Authors: Jassal, Davinder (Physiology) Singal, Pawan K.(Physiology)
Published: 2014
Subjects:
Cancer
Cardiomyopathy
Bevacizumab
Sunitinib
Cardiotoxicity
Echocardiography
Tissue velocity imaging
Biomarkers
Hemodynamics
Oxidative stress
Online Access:http://hdl.handle.net/1993/23884

Internet

http://hdl.handle.net/1993/23884

Similar Items